Report Categories
View AllRecent Articles
View All
LBRX LB Pharmaceuticals posts slightly smaller Q4 2025 loss than analyst estimates shares rise 366 percent
eXp World EXPI Stock Is It a Strong Investment Case Q4 2025 EPS Misses Estimates
ANVS Annovis Bio gains 152 percent on investor optimism despite posting a wider than expected Q4 2025 loss
The long term thesis for SonoTek Corporation SOTK in plain sight Slight Loss 20260508